Pfizer and others Subpoenaed in Drug Price Probe
An article posted today on kfgo.com reports that Pfizer Inc. is one of several drug companies subpoenaed by the U.S. Attorney’s
Read More
Part D/Prescription Drugs
Drug Spending in General, Insulin in Particular Raise Ire of the Public
It’s certainly no secret that the escalation in drug costs over the past few years has caught the attention–and raised
Read MoreInpatient or Outpatient? Be Aware of Getting Mooned!
The concept of a Medicare Outpatient Observation Notice (MOON) is something that many beneficiaries may not be aware of, but
Read MoreSeniors Advocate Drug Price Negotiation
A study conducted recently by The Senior Citizens League (TSCL) indicates that seniors have an overwhelming preference for Medicare’s negotiations
Read MoreSeniors encouraged to pay more attention to cost in selecting Part D plans
A study by researchers at Yale School of Management concludes that Medicare beneficiaries, when shopping for coverage, often do not end
Read MorePutting a Stop to Doctor-shopping for Painkillers
A new study has found state programs that require physicians to check drug registries before writing prescriptions for opioid pain
Read MoreFlu vaccine is only moderately protective this year, CDC says
(By Helen Branswell for STAT) This year’s flu vaccine is offering moderate protection against the main family of viruses causing
Read More5 Reasons Why An $89,000 Drug Has Congress Fuming
(By Sarah Jane Tribble and Sydney Lupkin for Kaiser Health News) The latest flashpoint in the ongoing debate over high
Read MoreDrugmaker Marathon ‘Pausing’ Delivery Of $89,000-a-year Muscular Dystrophy Drug
(By Sarah Jane Tribble and Sydney Lupkin for Kaiser Health News) In a surprise move Monday, Marathon Pharmaceuticals told patient
Read MoreMedicare Rules: Three that are Important to Know
There are more than 57 million Americans enrolled in Medicare, with more added to the program each month. Here are
Read More